Helene Peyriere
Overview
Explore the profile of Helene Peyriere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alawoe C, Chapet N, Roubille F, Peyriere H, Eiden C
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685731
Cocaine use can cause multiple cardiovascular complications, including heart failure. This general review of the literature delivers data on the relationship between cocaine consumption and the development of heart failure,...
2.
Daveluy A, Perino J, Gibaja V, Le Boisselier R, Batisse A, Miremont-Salame G, et al.
Therapie
. 2024 Nov;
PMID: 39537532
France has several monitoring systems that form the foundation of its health safety surveillance. This system is designed for the early detection of signals and their swift into an action...
3.
Lacroix C, Frauger E, Jouve E, Peyriere H, Micallef J
Therapie
. 2024 Nov;
PMID: 39516089
The OPPIDUM program was first created in 1990. It is an annual, repeated, cross-sectional, nationwide, multicenter program. Data are provided directly from users of psychoactive substances (PAS) seen in substance...
4.
Peyriere H, Dampierre A, Vallo R, Lestienne M, Eiden C, Donnadieu H
Arch Womens Ment Health
. 2024 Jul;
28(1):191-195.
PMID: 38980402
To specify psychoactive substances and related complications observed in spontaneous reports (SRs) in women versus men, we assessed SRs on substance-linked acute toxicity sent to a French Addictovigilance centre. Over...
5.
Bendjilali-Sabiani J, Eiden C, Lestienne M, Cherki S, Gautre D, Van den Broek T, et al.
Therapie
. 2024 Jun;
79(6):655-658.
PMID: 38845278
From 2019, in the United States and Europe, the synthetic opioid market has diversified with the appearance of the 2-benzylbenzimidazole family, commonly named "nitazenes". In vitro studies show that these...
6.
Mondesert E, Eiden C, Peyriere H, Formoso A, Corti L, Cristol J, et al.
Clin Toxicol (Phila)
. 2023 Nov;
61(9):674-679.
PMID: 37917184
Misuse of inhaled nitrous oxide is a growing concern in France. It is known to alter concentrations of vitamin B which is required as a cofactor for methionine synthase and...
7.
Diaz L, Eiden C, Jouanjus E, Frauger E, Fouilhe N, Djezzar S, et al.
Therapie
. 2023 Mar;
78(6):647-657.
PMID: 36918317
Objectives: Alprazolam, a high-potency and short-acting anxiolytic benzodiazepine, is one of the most misused benzodiazepines in France. In the context of various reports on alprazolam misuse during the COVID-19 pandemic,...
8.
Roy S, Eiden C, Nogue E, Picot M, Donnadieu-Rigole H, Peyriere H
Therapie
. 2022 Dec;
78(6):745-749.
PMID: 36517301
No abstract available.
9.
Nobile B, Eiden C, Peyriere H, Courtet P
Rev Prat
. 2022 Dec;
72(9):931.
PMID: 36512004
No abstract available.
10.
Peyriere H, Jacquet J, Peries M, Tribout V, Broche B, Mauboussin J, et al.
Fundam Clin Pharmacol
. 2022 Nov;
37(3):639-649.
PMID: 36403123
The assessment of mood disorders and addiction linked to the practice of chemsex is of interest given the psychoactive substances used. The aim of this study was to assess risky...